Outlook Therapeutics, Inc. (OTLK)
0.6405
-0.03
(-3.90%)
USD |
NASDAQ |
Sep 08, 16:00
0.6447
0.00 (0.00%)
Pre-Market: 08:05
Outlook Therapeutics Market Cap : 119.84M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 119.84M |
| September 04, 2026 | 124.70M |
| September 03, 2026 | 121.43M |
| September 02, 2026 | 117.18M |
| September 01, 2026 | 116.58M |
| August 31, 2026 | 118.51M |
| August 28, 2026 | 120.66M |
| August 27, 2026 | 119.95M |
| August 26, 2026 | 116.62M |
| August 25, 2026 | 119.74M |
| August 24, 2026 | 113.94M |
| August 21, 2026 | 121.09M |
| August 20, 2026 | 126.53M |
| August 19, 2026 | 129.12M |
| August 18, 2026 | 130.97M |
| August 17, 2026 | 125.77M |
| August 14, 2026 | 141.52M |
| August 13, 2026 | 92.98M |
| August 12, 2026 | 115.08M |
| August 11, 2026 | 118.21M |
| August 10, 2026 | 120.31M |
| August 07, 2026 | 106.71M |
| August 06, 2026 | 101.74M |
| August 05, 2026 | 107.75M |
| August 04, 2026 | 100.45M |
| Date | Value |
|---|---|
| August 03, 2026 | 95.51M |
| July 31, 2026 | 102.17M |
| July 30, 2026 | 108.80M |
| July 29, 2026 | 104.61M |
| July 28, 2026 | 94.57M |
| July 27, 2026 | 111.41M |
| July 24, 2026 | 146.98M |
| July 23, 2026 | 138.09M |
| July 22, 2026 | 140.18M |
| July 21, 2026 | 148.55M |
| July 20, 2026 | 144.37M |
| July 17, 2026 | 145.41M |
| July 16, 2026 | 152.74M |
| July 15, 2026 | 163.20M |
| July 14, 2026 | 180.98M |
| July 13, 2026 | 162.15M |
| July 10, 2026 | 164.24M |
| July 09, 2026 | 175.75M |
| July 08, 2026 | 176.80M |
| July 07, 2026 | 152.74M |
| July 06, 2026 | 148.55M |
| July 02, 2026 | 151.69M |
| July 01, 2026 | 153.78M |
| June 30, 2026 | 166.34M |
| June 29, 2026 | 176.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Valion Bio, Inc. | 0.4153M |
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
Market Cap Related Metrics
| PS Ratio | 116.60 |
| Price | 0.6405 |
| Earnings Yield | -176.6% |